TRIB1AL

Metabolic steatohepatitis (MASLD) — noncoding RNA therapeutic target

1 article(s) in the watch · Constitutional genetics

Curated publications

Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease

Metabolic steatohepatitis (MASLD) — noncoding RNA therapeutic target

Automatic aggregation page — a clinical introduction may be added.